Prosecution Insights
Last updated: August 06, 2026

Maxwell L Minch Esq. Pa

6 pending office actions • 5 clients • 5 examiners • 5 art units • 0 of 6 (0%) have an AI response strategy ready

Quality Metrics (n=202 apps, methodology: how we score firms)

70.6%
Allowance Rate
n=202
+0.23σ
Allowance Rate (norm)
n=202
3.2
OAs to Allowance
n=101
-0.16σ
OAs to Allow (norm)
n=101
941 days
Time to Allowance
n=101
+24.4pp
Interview Lift
n=202
28.7%
RCE Rate
n=202
1.2%
Appeal Rate
n=202

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=13 (min 20)
61.0%
§102 Overcome
n=77
64.1%
§103 Overcome
n=103
60.9%
§112 Overcome
n=87

Specialization & Scale

H02J, A61K, C12N
Top CPC Subclasses
13%
Top-3 CPC Share
n=202
0
Practitioners
n=202
Apps / Practitioner
n=202 (min 20)

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (50%)
2
Medium (33%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (17%)
§103 only2 (33%)
§112 only1 (17%)
Multi-statute (no §101)2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
17% of docket
1
Information Tech
17% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
67% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SU, SUSAN SHAN 2 71.9% +23.6%
MONTANARI, DAVID A 1 64.7% +49.1%
ORTIZ, RAFAEL ALFREDO 1 61.1% +35.4%
STOKLOSA, JOSEPH A 1 63.9% +19.6%
DINH, KHANH Q 1 83.7% +4.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18138028 METHOD AND SYSTEM FOR CREATING USER ACCOUNTS AND ESTABLISHING A COMMUNICATION LINK BETWEEN TWO USERS DINH, KHANH Q 23d

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18916696 DEVICES FOR PRE-WETTING WIPES AT POINT OF USE AND METHODS OF USE ORTIZ, RAFAEL ALFREDO 53d overdue
17171485 Transparent Tourniquet and Bandage Material System Utilizing Absorbing Components and Treatment Gas SU, SUSAN SHAN 17d overdue
17690814 BANDAGE SYSTEM FOR WOUND VISUALIZATION, MICROCURRENT THERAPY AND TOPICAL AND TRANSDERMAL DRUG DELIVERY SU, SUSAN SHAN 9d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18916696 DEVICES FOR PRE-WETTING WIPES AT POINT OF USE AND METHODS OF USE ORTIZ, RAFAEL ALFREDO 53d overdue
17171485 Transparent Tourniquet and Bandage Material System Utilizing Absorbing Components and Treatment Gas SU, SUSAN SHAN 17d overdue
18233888 Wearable lumbo-pelvic active balancing device and methods of use STOKLOSA, JOSEPH A 9d
17690814 BANDAGE SYSTEM FOR WOUND VISUALIZATION, MICROCURRENT THERAPY AND TOPICAL AND TRANSDERMAL DRUG DELIVERY SU, SUSAN SHAN 9d
18866750 GENETICALLY ENGINEERED MUCOSAL-ASSOCIATED INVARIANT T (MAIT) CELLS FOR ADOPTIVE TRANSFER CELLTHERAPY MONTANARI, DAVID A

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
37812
16321
37361
37941
24581

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18866750 GENETICALLY ENGINEERED MUCOSAL-ASSOCIATED INVARIANT T (MAIT) CELLS FOR ADOPTIVE TRANSFER CELLTHERAPY Hadasit Medical Research Services And Development Ltd. MONTANARI, DAVID A 1632 §103 Non-Final OA Pending Nov 18, 2024
18916696 DEVICES FOR PRE-WETTING WIPES AT POINT OF USE AND METHODS OF USE Peer Innovations, LLC ORTIZ, RAFAEL ALFREDO 3736 §101§102§112Other Non-Final OA 53d overdue Pending Oct 15, 2024
18233888 Wearable lumbo-pelvic active balancing device and methods of use Symetrify Ltd. STOKLOSA, JOSEPH A 3794 §112 Non-Final OA 9d Pending Aug 15, 2023
18138028 METHOD AND SYSTEM FOR CREATING USER ACCOUNTS AND ESTABLISHING A COMMUNICATION LINK BETWEEN TWO USERS Onoff Telecom DINH, KHANH Q 2458 §103 Final Rejection 23d Pending Apr 21, 2023
17690814 BANDAGE SYSTEM FOR WOUND VISUALIZATION, MICROCURRENT THERAPY AND TOPICAL AND TRANSDERMAL DRUG DELIVERY Clear Care Products, Inc. SU, SUSAN SHAN 3781 §103§112Other Non-Final OA 9d Pending Mar 09, 2022
17171485 Transparent Tourniquet and Bandage Material System Utilizing Absorbing Components and Treatment Gas Clear Care Products, Inc. SU, SUSAN SHAN 3781 §102§103 Final Rejection 17d overdue Pending Feb 09, 2021

Managing Maxwell L Minch Esq. Pa's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month